Hoth Therapeutics
HOTH • NASDAQ
Hoth Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robb Knie, with a market cap of $14.3M.
Market Cap$14.3M
Employees3.0
CEORobb Knie
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsJun 3, 2026 · in a monthAfter Market Close · Q1 2026
Financials
Hoth Therapeutics FAQ
Common questions about Hoth Therapeutics
Hoth Therapeutics is scheduled to report earnings for Q1 2026 on June 3, 2026 after market close.
Hoth Therapeutics has approximately 3 employees.